目的建立异种小血管支架模型。
Objective To establish a scaffold model from heterogeneous small blood vessels.
结果运用旋转成管法，成功制备了血管支架；
Results Tubular vascular scaffolds were successfully made by rotation method.
梗死相关血管支架的置入率为96 . 7%。
构建组织工程化血管就必然涉及血管支架的预制。
The prefabrication of vascular scaffold will be involved in engineering a blood vessel substitute.
采用该工艺参数，切割出了高质量的心血管支架。
The high quality coronary artery stents have been cut with the output power o...
所说的壳聚糖血管支架是用壳聚糖纤维编织而成。
所说的壳聚糖非血管支架是用壳聚糖纤维编织而成。
The chitosan non-vessel stent is formed by weaving chitosan fibers.
不凝血材料在小直径血管支架领域具有很大的应用潜力。
The search for a nonthrombogenic material with the potential for use in small diameter vascular graft applications continues to be a field of extensive investigation.
提出了血管支架形状系数概念，用以描述形状的力学性能。
In this paper, we advance a concept, shape coefficient, to describe the mechanical properties of shape factor concretely.
王亚莉，魏蜀亮，赖应龙，贾维心血管支架置入与凝血反应。
Wang Y. -L. , Wei S. -L. , Lai Y. -L. , Jia W. -K. Implantation of cardiovascular stent and coagulation response.
目的探讨壳聚糖管和生物蛋白胶作为工程化血管支架的可行性。
ObjectiveTo investigate the feasibility of construction of engineered blood vessel using chitosan tube and fibrin gel as scaffold.
本实用新型涉及一种网格型血管支架，属于医疗器械技术领域。
The utility model relates to a lattice type blood vessel dilator, which belongs to medicine equipment technical field.
目的：阐述脑血管支架的治疗进展，评价其与宿主间的生物相容性。
OBJECTIVE: to investigate therapeutic progress of cerebral intravascular stent, and to evaluate biocompatibility with host.
本发明属于医用材料领域，具体涉及壳聚糖非血管支架及其制备方法。
The invention belongs to the field of medical materials, in particular to chitosan non-vessel stent and preparation method thereof.
该结果表明NGF能够显著增强血管内皮祖细胞的迁移与归巢到血管支架上。
These results demonstrated that NGF can markedly increase EPCs mobilization and homing to vascular grafts.
目的对已成功制备的以脱细胞犬动脉为基质的血管支架进行体外再细胞化研究。
Objective To recellularize a novel tissue engineered blood vessel (TEBV) scaffold based on decellularized canine aorta which we had successfully constructed.
由于该模拟分析中可以了解到血管支架在植入人体后，及可能产生的破坏位置点；
Try the cardiovascular stent of computational analysis before implantation into the human body at the same time , the fatigue life under the load function of specific cycle ;
股票价格下跌是由于欧洲医学会议的一系列关于血管支架安全方面的报道引起的。
The declines came after a stream of reports about stent safety from a European medical meeting.
目的：探讨脑血管支架成形术后高灌注综合征(HPS)的临床诊断与治疗方法。
Objective: Clinical recognition and treatment of hyperperfusion syndrome (HPS) following cerebral artery stenting have been summarized.
撑开均匀性是血管支架的一个重要力学性能，它对于筋的安全性有极大的影响作用。
Expansion uniformity is an important mechanic property of intravascular stent, which produce a critical effect on safety of the stent.
目的：研究PT CA及血管支架安装治疗急性心肌梗死的时机选择与心脏功能关系。
Objective: to study relation between the choice of right moment and heart function to treat AMI with PTCA and stent.
方法：回顾性分析了2例脑血管支架成形术后hps的临床和影像学资料及诊治经过。
Methods: The clinical and radiological informations of 2 patients with HPS following cerebral artery stenting were reviewed.
血管支架是置于动脉管内的金属套管，用于在清除血管阻塞医学治疗后维持血管畅通。
Stents are metal sleeves inserted in arteries to keep them propped open after medical procedures to clear blockages.
结论抗体偶联胶原包被质粒DNA血管支架是一种新型高效、局部定位的基因转染体系。
Conclusions Anti-DNA antibody modified stents represent a novel highly efficient and site-specific gene delivery system which can deliver various kinds of plasmid vectors.
心脏病人的寿命越来越长，在血管支架、心脏搭桥或者心瓣膜置换手术后，病人最长可以活20年。
Cardiac patients are living longer and longer — up to 20 years after receiving stents, a heart bypass, or heart-valve replacements.
在儿童期以经心导管放置血管支架，对外科手术不合适的周边肺动脉狭窄，是可以接受的治疗方法。
Transcatheter placement of the stent is a feasible and effective method to treat certain patients with significant pulmonary arterial stenosis if surgical correction can not be performed.
在优选实施方式中，植入式医疗装置包括一植入式管腔假体，例如血管支架、非血管支架和支架移植物。
In preferred embodiments, the implantable medical device comprises an implantable luminal prosthesis, such as vascular and non-vascular stents and stents grafts.
谢潮鑫，孟猛，曾伟杰，钟磊，魏春霞，罗佼心血管支架材料生物力学及生物相容性与支架置入后血管再狭窄。
Xie C. -X. , Meng M. , Zeng W. -J. , Zhong L. , Wei C. -X. , Luo J. Biomechanics and biocompatibility of cardiovascular stent materials and restenosis following stent implantation.
所得物保持原来支架的长度和直径，由胶原蛋白和平滑肌细胞组成，其结构类似天然血管。
The result is a tube of the length and diameter of the original scaffold, that is composed of collagen and smooth-muscle cells—a structure similar to a natural blood vessel.
所得物保持原来支架的长度和直径，由胶原蛋白和平滑肌细胞组成，其结构类似天然血管。
The result is a tube of the length and diameter of the original scaffold, that is composed of collagen and smooth-muscle cells—a structure similar to a natural blood vessel.
应用推荐